Galectin Therapeutic (GALT)

$3.76 0.10 (2.73%)

16:00 EDT GALT Stock Quote Delayed 30 Minutes

Chris MacDonald

GALT Stock: The Big Trial News That Has Galectin Therapeutics Soaring

By Chris MacDonald, InvestorPlace Contributor Jul 9, 2021

Today, a key announcement of some positive clinical trial data has sent investors in Galectin and GALT stock on a nice ride.

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Friday Morning

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Wednesday Morning

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Wednesday Morning

More Articles

Volume:

Previous Close -

Market Cap 222.87M

PE Ratio -7.67

EPS -0.49

Volume (Avg. Vol.) 365,484

Day's Range 3.66 - 3.95

52-Week Range 1.82 - 5.70

Dividend & Yield N/A (N/A)

GALT Stock Predictions, Articles, and Galectin Therapeutic News

From InvestorPlace
From the Web

5 Biotech Stocks to Play the Sector’s Next Big Trend: NASH

By Aaron Levitt, InvestorPlace Contributor Sep 26, 2018

Looking for blockbuster potential? These five biotech stocks may have found it in treating NASH -- an untapped market of up to $35 billion.

5 Clinical-Stage Biotech Stocks to Buy Under $10

By Aaron Levitt, InvestorPlace Contributor May 29, 2018

Clinical-stage biotech stocks offer plenty of promise to investors looking to take on some risk. Here are five to buy today.

25 Biotechnology Stocks to Buy Now

By Portfolio Grader Oct 3, 2016

25 Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

Hottest Manufacturing Stocks Now – ARRY CHMT SMMT SELB

By Portfolio Grader Sep 26, 2016

The following stocks were moving the Manufacturing sector today.

Biggest Movers in Manufacturing Stocks Now – GALT CERC OVAS EBIO

By Portfolio Grader Sep 21, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

13 Biotechnology Stocks to Sell Now

By Portfolio Grader Jul 18, 2016

The ratings of 13 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

29 Biotechnology Stocks to Sell Now

By Portfolio Grader Jun 27, 2016

This week, the overall grades of 29 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

28 Biotechnology Stocks to Sell Now

By Portfolio Grader Jun 20, 2016

This week, the overall grades of 28 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

27 Biotechnology Stocks to Sell Now

By Portfolio Grader May 16, 2016

The ratings of 27 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Biotech Stocks With Upside Target Ebola, Liver Disease

By The Life Sciences Report, Streetwise Reports Sep 16, 2014

Developing successful Ebola and liver disease treatments is an incredibly risky opportunity for biotech stocks to create value.

61 Biggest Movers From Yesterday

From Benzinga Aug 3, 2021

Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 124.8% to close at $5.08 on Monday after the company announced a $5 million stock repurchase program....

40 Stocks Moving In Monday's Mid-Day Session

From Benzinga Aug 2, 2021

Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares jumped 133% to $5.27 after the company announced a $5 million stock repurchase program. Exicure, Inc. (NASDAQ:...

Is Galectin Therapeutics a Good Cancer Stock to Own?

From StockNews.com Jul 16, 2021

Galectin Therapeutics (GALT) is a leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer. The company has made solid progress in developing its leading drug candidate, Belapectin, for the treatment of melanoma and head and neck cancer. However, given that the products in GALT’s pipeline are still far from ready for commercialization, is it worth betting on the stock now? Read on.

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

From Benzinga Jul 14, 2021

Gainers Qualigen Therapeutics (NASDAQ:QLGN) stock moved upwards by 8.98% to $1.94 during Wednesday's pre-market session. The market value of their outstanding shares...

26 Stocks Moving in Wednesday's Pre-Market Session

From Benzinga Jul 14, 2021

Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) shares rose 35.6% to $3.54 in pre-market trading after jumping around 12% on Tuesday. Oxbridge Re Holdings Limited (NASDAQ: OXBR) shares...

64 Biggest Movers From Yesterday

From Benzinga Jul 14, 2021

Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares climbed 128.8% to settle at $9.06 on Tuesday. Red Cat Holdings, Inc. (NASDAQ: RCAT) surged 60.3% to settle at $4.76...